Insider Transactions in Q4 2022 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Bona fide gift
|
Direct |
19
-0.21%
|
-
|
|
Dec 13
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Bona fide gift
|
Direct |
40
-0.43%
|
-
|
|
Nov 26
2022
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
30,047
-19.72%
|
-
|
|
Nov 26
2022
|
Thomas E Polen Jr Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
72,980
+21.97%
|
-
|
|
Nov 26
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Payment of exercise price or tax liability
|
Direct |
232
-10.84%
|
-
|
|
Nov 26
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
BUY
Grant, award, or other acquisition
|
Direct |
669
+14.48%
|
-
|
|
Nov 26
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,908
-17.01%
|
-
|
|
Nov 26
2022
|
Samrat S. Khichi EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,290
+20.66%
|
-
|
|
Nov 26
2022
|
Roland Goette EVP and President EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-0.72%
|
-
|
|
Nov 26
2022
|
Roland Goette EVP and President EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
1,819
+6.38%
|
-
|
|
Nov 26
2022
|
Pavan Kumar Mocherla EVP & President Greater Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-3.91%
|
-
|
|
Nov 26
2022
|
Pavan Kumar Mocherla EVP & President Greater Asia |
BUY
Grant, award, or other acquisition
|
Direct |
462
+16.47%
|
-
|
|
Nov 26
2022
|
David Hickey EVP & President, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,816
+26.08%
|
-
|
|
Nov 26
2022
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-2.2%
|
-
|
|
Nov 26
2022
|
Christopher Del Orefice EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,087
+20.16%
|
-
|
|
Nov 26
2022
|
Antoine C Ezell EVP, President NA & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-1.37%
|
-
|
|
Nov 26
2022
|
Antoine C Ezell EVP, President NA & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+11.1%
|
-
|
|
Nov 26
2022
|
Shana Carol Neal EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,812
+16.15%
|
-
|
|
Nov 26
2022
|
Richard Byrd EVP & President Interventional |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-11.37%
|
-
|
|
Nov 26
2022
|
Richard Byrd EVP & President Interventional |
BUY
Grant, award, or other acquisition
|
Direct |
2,501
+18.35%
|
-
|
|
Nov 26
2022
|
Michael David Garrison EVP & President Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
617
-8.49%
|
-
|
|
Nov 26
2022
|
Michael David Garrison EVP & President Medical |
BUY
Grant, award, or other acquisition
|
Direct |
2,790
+17.5%
|
-
|
|
Nov 16
2022
|
Roland Goette EVP and President EMEA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,996
-20.11%
|
$665,112
$222.08 P/Share
|
|
Nov 16
2022
|
Roland Goette EVP and President EMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,617
+23.66%
|
$341,658
$74.94 P/Share
|